Rivaroxaban Mylan
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
assessment-report
medication.label.permit_number
EMA/560715/2021
medication.label.permit_validity
First published: 2021-11-29T13:32:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live